Labcorp Announces 2025 Fourth Quarter and Full Year Results

About this update from Labcorp Holdings Inc.

[{"type":"text","content":"Company Provides 2026 Guidance","length":30,"tagName":"p","attribs":{}},{"type":"list","items":[{"val":[{"type":"text","content":"Financial results from Operations versus 2024:","length":46,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue: Q4 of $3.52 billion vs $3.33 billion; Full year of $13.95 billion vs $13.01 billion","length":92,"tagName":"p"}]},{"val":[{"type":"text","content":"Diluted EPS: Q4 of $1.98 vs $1.70; Full year of $10.46 vs $8.84","length":63,"tagName":"p"}]},{"val":[{"type":"text","content":"Adjusted EPS: Q4 of $4.07 vs $3.45; Full year of $16.44 vs $14.57","length":65,"tagName":"p"}]},{"val":[{"type":"text","content":"Free Cash Flow: Q4 of $490.3 million vs. $665.1 million; Full year of $1.21 billion vs $1.10 billion","length":100,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":320,"olType":false}]},{"val":[{"type":"text","content":"Provided Full-Year 2026 Enterprise Revenue, Adjusted EPS and Free Cash Flow guidance:","length":85,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue of $14.61 billion to $14.79 billion; midpoint growth of 5.4%","length":68,"tagName":"p"}]},{"val":[{"type":"text","content":"Adjusted EPS of $17.55 to $18.25; midpoint growth of 8.9%","length":57,"tagName":"p"}]},{"val":[{"type":"text","content":"Free Cash Flow of $1.24 billion to $1.36 billion; midpoint growth of 7.8%","length":73,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":198,"olType":false}]},{"val":[{"type":"text","content":"Expanded partnerships with health systems and regional/local laboratories by signing or closing 13 transactions in 2025","length":119,"tagName":"p"}]},{"val":[{"type":"text","content":"Advanced leadership in specialty testing, launching more than 130 innovative new tests in 2025, including in oncology, women's health, neurology and autoimmune","length":163,"tagName":"p"}]},{"val":[{"type":"text","content":"Announced strategic investment to build a modern, state-of-the-art 500,000 square foot Central Laboratory facility to address growth in demand","length":142,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":1073,"olType":false},{"type":"text","content":"BURLINGTON, N.C., Feb. 17, 2026 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory s...

More updates from Labcorp Holdings Inc.